Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis
Recruiting now
Conditions studied: Monoclonal Gammopathies, Multiple Myeloma, M-protein
In brief
To provide a comprehensive MALDI-TOF mass spectrometry method for detecting, characterizing, and quantifying M-protein, and to track M-protein in a very sensitive and specific manner during patient treatment, providing a more precise test for diagnosing disease and monitoring patient response to treatment.
Key facts
- Study ID
- NCT05686447
- Run by
- Zhujiang Hospital
- People needed
- 200
- Starts
- 2023-01-01
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2025-04-06
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Zhujiang Hospital of Southern Medical University — Guangzhou, Guangdong, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.